Mon, Jun 24, 2024
Biocon Biologics, a subsidiary of Biocon, on Monday got approval from the European Medicines Agency (EMA) to manufacture biosimilar Bevacizumab in India.
More >
Tue, Jun 18, 2024
India's pharma exports grew by 10.45 per cent in May this year to touch the $2.3 billion mark compared with the $2.08 billion in the same month of the previous financial year.
Mon, Nov 27, 2023
Top executives at the firms said some customers want to add India as a second source, in addition to China, for manufacturing.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
